The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Mark D. Trone
Advertisement
Articles by Mark D. Trone
The authors explore and define common industry approaches and practices when applying GMPs in early development.
The authors explore and define common industry approaches and practices when applying GMPs in early development.
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
IQ Consortium representatives explore industry approaches for applying GMPs in early development.
Advertisement
Latest Updated Articles
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)Published: October 2nd 2012 | Updated:
GMPs for Method Validation in Early Development: An Industry Perspective (Part II)Published: July 2nd 2012 | Updated:
GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VIPublished: November 2nd 2014 | Updated:
Part VII GMPs for Small Molecule Drugs in Early Development Workshop SummaryPublished: December 2nd 2014 | Updated:
Evaluating Progress in Analytical Quality by DesignPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
